Exercise decreases among people taking GLP-1 medication
Reports and Proceedings
Updates every hour. Last Updated: 27-Oct-2026 19:16 ET (27-Oct-2026 23:16 GMT/UTC)
Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study being presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Ill.
A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases patients’ risk of cardiovascular complications, according to a study being presented Saturday at ENDO 2026, the Endocrine Society’s annual meeting in Chicago, Ill.
Researchers have developed a new way of testing for foetal abnormalities using a simple blood draw from the mother that is able to identify a very high proportion of the clinically relevant genetic variants that are currently only detectable by invasive testing.
https://researching.cn/EN/JournalEarlyPostingIssue/fsr
This Special Issue addresses the significant challenges associated with the identification of human remains in both routine forensic casework and extraordinary circumstances. It highlights advances in multidisciplinary approaches, emerging technologies, and best practices that support accurate and reliable identification across a wide range of contexts, including decomposed, fragmented, burned, and disaster-related remains.